Interestingly, the age adjusted geometric means (GM) of sCD163 in CSF were significantly elevated for patients in the RRMS (p = 0.026), PPMS (p = 0.011), and CIS (p = 0.014) groups compared with the SC group. This evidence concerns the gene CD163 and in situ carcinoma.